ESR1 and breast carcinoma: In a large Danish cohort, Pedersen et al. reported that breast cancer recurrence can occur even 10-32 years after primary surgery, particularly among ER-positive patients, with approximately 16% experiencing very late relapse, underscoring the lifelong risk of recurrence in this subgroup [18].